CLINICAL_TRIALS
research
· 2025-03-21
Clinical Trial Update: Optimal Timing of Hepatitis B Vaccination After Transplants [Phase 3]
Summary
A Phase 3 trial update discusses the optimal timing of Hepatitis B vaccination after transplantation and notes that recruitment has not yet started.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Transplant-Related Disorder, Hepatitis B Virus Infection | Phase 3 | Status: NOT_YET_RECRUITING